Melbourne Vaccine Education Centre - MVEC

👋 Meet Capvaxive – the latest vaccine to join the National Immunisation Program (NIP)

🗓️💉 From 1 July 2026, Capvaxive will replace Prevenar 13 and Pneumovax 23 for adults, including:
🔸those with specified medical conditions from 18 years
🔸First Nations adults from 25 years
🔸non-Indigenous adults from 65 years.

Generally, only 1 dose is required in a lifetime 👍

❄️ Capvaxive must be stored between 2°C and 8°C.
It must be protected from light

A single 0.5 mL dose comes as a pre-filled syringe

Capvaxivce can be safely co-administered with other vaccines ✅💉💉

For more information, visit MVEC’s pneumococcal reference page linked in our bio 🔗

📣 RSV Awareness Week is running from 7-13 June 2026

🫁🤧 RSV is a common respiratory virus that can be serious for babies, young children, older adults and people with certain health conditions

With immunisation options now available for infants and older adults, RSV Awareness Week is a reminder to learn more, ask questions and speak with a health professional about protection 💉🛡️

For RSV information and resources from the Immunisation Foundation of Australia, visit: www.ifa.org.au/uniteagainstrsv

📰 News: The National Immunisation Program (NIP) adult pneumococcal schedule is changing on 1 July 2026 🗓️

The 21-valent pneumococcal conjugate vaccine Capvaxive will replace Prevenar 13 and Pneumovax 23. 💉

👀 Stay to tuned for more information in the leadup to the switch!

📰 News: The National Immunisation Program (NIP) adult pneumococcal schedule is changing on 1 July 2026 🗓️

The 21-valent pneumococcal conjugate vaccine Capvaxive will replace Prevenar 13 and Pneumovax 23 💉

👀 Stay to tuned for more information in the leadup to the switch!

If your child is getting a BCG vaccine, check if they need a measles vaccine too! They can get the MMR vaccine the same day as BCG, or 4 weeks apart ✅

The number of measles infections is increasing in Australia and all around the world 📈 🌏

For everyone born in 1966 or later, 2 doses of measles-containing vaccine are required to be protected 🛡️

✈️ Infants as young as 6 months who are travelling are recommended to have an MMR vaccine.

🗓️ If they are aged 6 to 11 months, this will be an extra dose before their routine 12-month and 18-month doses
🗓️ If they are between 11 and 12 months it will count as their 12-month dose then they will complete their 18-month dose as normal.

‼️ Reminder: both BCG and MMR are not safe for people with immunocompromise, or for pregnant people ‼️

VaccineEducation

Swipe through for key information about the current diphtheria outbreak including:
🔹 the current state of play
🔹 what should you do.

Let’s deep dive how influenza vaccine coverage is tracking in 2026 compared to the last 3 years 🤔📊

2026 coverage rates are ahead in all age groups < 18 years! It’s fantastic to see children of all ages being protected 😊🛡️

Adults need to catch up – the 18 to < 50 years and 50 to

🦠 Different information, for different generations, in different messaging 🦠

RSV for protection for gens: Beta 🤝 Alpha 🤝 Z 🤝 Millennial 🤝 X 🤝 Baby Boomers 🤝 Silent 🤝 Greatest

(Our millennials reflexes won’t let us not tell you that there is more information on RSV protection on our reference page linked in our bio 🔗👍🙂)

*** REPOST: It’s been a couple of years now since we met Arexvy, and now, as of 15 May 2026, it is funded on the NIP for eligible older adults 🥳

✍️ We’ve refreshed our Meet Arexvy post with updated information about vaccine recommendations and funding. Let us know in the comments if you have any questions 👇 ***

📢 In January 2024, Arexvy was registered by the Therapeutic Goods Administration (TGA). It is available for the prevention of respiratory syncytial virus (RSV) in adults 60 years and older (or 50 years and older and at increased risk for RSV disease) 🦠🤒

A course of vaccination requires a single dose. Arexvy can be administered at any time of year and may be co-administered with other vaccines 💉💪

Common side effects include injection site reactions, headache, malaise and fatigue. These side effects typically last 1-2 days and can be managed at home with symptomatic relief 🤒

Arexvy is now funded on the National Immunisation Program (NIP) for all adults ≥ 75 years and First Nations adults ≥ 60 years 👏🙌🎉

🤓 For more information, visit MVEC’s RSV reference page via the in our bio!